Certara Services Archives

Case Study

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

CertaraOctober 2, 2025

Conference

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

CertaraSeptember 22, 2025

Blog

Best Practices in Clinical Pharmacology Gap Analysis

September 19, 2025 Submitting your New Drug Application (NDA) to the FDA is the ultimate…

CertaraSeptember 19, 2025

Announcement

Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC

Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights,…

CertaraSeptember 17, 2025

Press Coverage

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

Explore the top challenges in cell & gene therapy commercialization, featuring expert insights from Fran…

CertaraSeptember 12, 2025

Guide

The Top 10 Things You Need to Know About ADNCA Datasets

Learn how ADNCA datasets can modernize non-compartmental analysis: enhanced compliance, automations, and faster PK data…

CertaraSeptember 11, 2025

Webinar

TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind

CertaraSeptember 10, 2025

Press Coverage

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…

Danielle PillsburySeptember 10, 2025

Press Coverage

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…

CertaraSeptember 9, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

CertaraSeptember 5, 2025

Certara Services

Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer

37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT)

Best Practices in Clinical Pharmacology Gap Analysis

Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC

What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization?

The Top 10 Things You Need to Know About ADNCA Datasets

TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

Redefining Every Stage of Investment (RESI) Seed to Exit

Newsletter sign up

Quick links

Solutions

Contact